These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 4721187)

  • 21. [Juvenile otosclerosis].
    Sicard F; Desjardins R
    Union Med Can; 1970 Sep; 99(9):1639-41. PubMed ID: 5527441
    [No Abstract]   [Full Text] [Related]  

  • 22. Fluoride and osteoporosis.
    Dequeker J; Burssens A
    Br Med J; 1973 Mar; 1(5852):551. PubMed ID: 4692692
    [No Abstract]   [Full Text] [Related]  

  • 23. Meniere's disease and otosclerosis (without oval window involvement).
    Cole JM; Funkhouser G
    Laryngoscope; 1972 Jun; 82(6):1027-34. PubMed ID: 5036235
    [No Abstract]   [Full Text] [Related]  

  • 24. [Treatment of osteoporosis with sodium fluoride].
    Swiderska-Kulikowa B
    Pol Arch Med Wewn; 1975 Feb; 53(2):171-7. PubMed ID: 1089959
    [No Abstract]   [Full Text] [Related]  

  • 25. Enzymology of otospongiosis and NaF therapy.
    Causse JR; Shambaugh GE; Causse B; Bretlau P
    Am J Otol; 1980 Apr; 1(4):206-14. PubMed ID: 6969991
    [No Abstract]   [Full Text] [Related]  

  • 26. [Results of conservative treatment of otosclerosis by endoaural electrophoresis of fluorine preparations and ascorbic acid].
    Gukovich VA; Avramenko LV; Martyniuk LA
    Zh Ushn Nos Gorl Bolezn; 1977; (2):21-8. PubMed ID: 855459
    [No Abstract]   [Full Text] [Related]  

  • 27. Adult fluoride therapy for ostosclerosis (otospongiosis).
    Shambaugh GE
    Arch Otolaryngol; 1983 May; 109(5):353. PubMed ID: 6847492
    [No Abstract]   [Full Text] [Related]  

  • 28. Sodium fluoride in otosclerosis treatment: review.
    Cruise AS; Singh A; Quiney RE
    J Laryngol Otol; 2010 Jun; 124(6):583-6. PubMed ID: 20163750
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modification with NaF in disequilibrium of otospongiotic origin.
    Bretlau P; Causse JB; Causse J
    Adv Otorhinolaryngol; 1982; 28():73-9. PubMed ID: 7113821
    [No Abstract]   [Full Text] [Related]  

  • 30. Fluoride therapy for osteoporotic lesions.
    Parkins FM
    Ann Otol Rhinol Laryngol; 1974; 83(5):626-34. PubMed ID: 4606556
    [No Abstract]   [Full Text] [Related]  

  • 31. Fluoride.
    Janeke JB
    S Afr Med J; 1978 Sep; 54(12):470. PubMed ID: 734573
    [No Abstract]   [Full Text] [Related]  

  • 32. Otosclerosis: incidence of positive findings on high-resolution computed tomography and their correlation to audiological test data.
    Naumann IC; Porcellini B; Fisch U
    Ann Otol Rhinol Laryngol; 2005 Sep; 114(9):709-16. PubMed ID: 16240935
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnosis and treatment of cochlear otosclerosis.
    Arch Otolaryngol; 1973 Jan; 97(1):30-4. PubMed ID: 4684904
    [No Abstract]   [Full Text] [Related]  

  • 34. Sodium fluoride as a treatment for otosclerotic hearing loss.
    Linthicum FH; Forquer BD
    Am J Otol; 1985 Jan; 6(1):35-7. PubMed ID: 3976857
    [No Abstract]   [Full Text] [Related]  

  • 35. Sodium fluoride: effectiveness of treatment for cochlear otosclerosis.
    Forquer BD; Linthicum FH; Bennett C
    Am J Otol; 1986 Mar; 7(2):121-5. PubMed ID: 3963156
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sodium fluoride in therapy of otosclerosis--does it cause atherosclerosis?
    Baron SH
    Laryngoscope; 1967 Aug; 77(8):1227-33. PubMed ID: 6072049
    [No Abstract]   [Full Text] [Related]  

  • 37. Experiments and experiences with sodium fluoride for inactivation of the otosclerotic lesion.
    Shambaugh GE; Sundar VS
    Laryngoscope; 1969 Oct; 79(10):1754-64. PubMed ID: 5345408
    [No Abstract]   [Full Text] [Related]  

  • 38. Otospongiosis and sodium fluoride. A clinical double-blind, placebo-controlled study on sodium fluoride treatment in otospongiosis.
    Bretlau P; Salomon G; Johnsen NJ
    Am J Otol; 1989 Jan; 10(1):20-2. PubMed ID: 2655462
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparative clinical study investigating the efficacy of a test dentifrice containing 8% strontium acetate and 1040 ppm sodium fluoride versus a marketed control dentifrice containing 8% arginine, calcium carbonate, and 1450 ppm sodium monofluorophosphate in reducing dentinal hypersensitivity.
    Hughes N; Mason S; Jeffery P; Welton H; Tobin M; O'Shea C; Browne M
    J Clin Dent; 2010; 21(2):49-55. PubMed ID: 20669816
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Editorial: therapeutic use of fluorides.
    Best EJ
    Dent Dig; 1966 Aug; 72(8):367. PubMed ID: 5221320
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.